Morphine-induced fetal malformations. 3. Possible mechanisms of action.
D000014:Abnormalities, Drug-Induced / Q000209:etiology*; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001522:Behavior, Animal / Q000187:drug effects; D001786:Blood Glucose; D001921:Brain / Q000002:abnormalities; D002800:Cholinesterase Inhibitors / Q000494:pharmacology; D004357:Drug Synergism; D005260:Female; D005333:Fetus / Q000378:metabolism; D006339:Heart Rate / Q000187:drug effects; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D009020:Morphine / Q000009:adverse effects* / Q000494:pharmacology; D010830:Physostigmine / Q000009:adverse effects; D010920:Placenta / Q000378:metabolism; D011247:Pregnancy; D012863:Skeleton; D012964:Sodium / Q000378:metabolism; D012975:Sodium Isotopes; D013737:Testis / Q000002:abnormalities; D013997:Time Factors
D001786:Blood Glucose; D002800:Cholinesterase Inhibitors; D012975:Sodium Isotopes; D009020:Morphine; D001285:Atropine; D012964:Sodium; D010830:Physostigmine